Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Fish and Richardson
Harvard Business School

Generated: March 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022568

« Back to Dashboard

NDA 022568 describes ARICEPT, which is a drug marketed by Eisai Inc and is included in four NDAs. It is available from seven suppliers. There is one patent protecting this drug and two Paragraph IV challenges. Additional details are available on the ARICEPT profile page.

The generic ingredient in ARICEPT is donepezil hydrochloride. There are thirty-one drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride profile page.
Summary for 022568
Applicant:Eisai Inc
Ingredient:donepezil hydrochloride
Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 022568
Mechanism of ActionCholinesterase Inhibitors
Suppliers and Packaging for NDA: 022568
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ARICEPT donepezil hydrochloride TABLET;ORAL 022568 NDA Eisai Inc. 62856-247 N 62856-247-30
ARICEPT donepezil hydrochloride TABLET;ORAL 022568 NDA Avera McKennan Hospital 69189-0247 N 69189-0247-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength23MG
Approval Date:Jul 23, 2010TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Oct 4, 2026Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.